Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07365150
Eligibility Criteria:
Inclusion Criteria:
* Primary ICH Diagnosis
* Age ≥ 18 years
* Within 6 hours of ICH
* Supratentorial ICH
* GCS ≥8
* Location-specific volume criteria (\>7ml for thalamus or internal capsule; \>30ml for putamen or lobar)
Exclusion Criteria:
* Severe pre-morbid disability (Pre-morbid modified Rankin scale 5)
* Anticipated surgical treatment
* Recent acute atherosclerotic cardiovascular diseases (e.g. acute coronary syndrome, ischemic stroke)
* Receiving anticoagulation
* Recent intravascular stent placement and on dual antiplatelet treatment
* Expected life expectancy of \<1 year
* Inability to participate in follow-up activity
* Bleeding tendency
* Severe renal impairment
* Severe liver impairment
* Known contraindication or allergy to tranexamic acid
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07365150
Study Brief:
Protocol Section:
NCT07365150